CAITLIN CANTER

Health care reform including implementation of the Affordable Care Act. Monitor implementation of the No Surprises Act. Coronavirus response efforts, including support for health care providers, patients and small business, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Recovery audit contractor reform. Medicare regulatory reform, including physician payment reforms. Network adequacy oversight. Prior authorization reform, including related provisions in H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans, and H.R. 3173/S. 3018, the Ensuring Seniors Timely Access to Care Act. Medicare accountable care organizations. Electronic health record interoperability and vendor accountability. Physician-owned-hospital barriers, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act, and S. 4130, the Patient Access to Higher Quality Care Act of 2022. Coronavirus response efforts, including support for health care providers, patients and small business, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Medicare physician fee schedule and sequestration relief. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including: (1) provisions in H.R. 5376, the Build Back Better Act, Section 139001, to establish a Drug Price Negotiation Program, and modify Medicare Part B reimbursement by application of Maximum Fair Prices and Conforming Amendments, to selected Medicare Part B covered drugs; and (2) monitor the CMMI Most Favored Nation demonstration.

340B Program issues and patient access to pharmaceuticals, including related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022, P.L. 117-103. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines, including related provisions in H.R. 7667, Food and Drug Amendments Act and S. 4348, Food and Drug Administration Safety and Landmark Advancements Act; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2) and H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

Monitor implementation of healthcare quality, cost, and access and related health care reform efforts. Coronavirus response efforts, including support for health care providers and patients, and related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Monitor healthcare reform and quality initiatives, including implementation of related provisions in the Affordable Care Act. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act and H.R.1667, Dr. Lorna Breen Health Care Provider Protection Act (Public Law No: 117-105), and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-owned hospitals, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act of 2021, and S. 4130, the Patient Access to Higher Quality Care Act of 2022; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-owned hospitals. Coronavirus response efforts, including support for health care providers, patients and small business, and enable physician-owned hospitals to respond to COVID-19, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2022, P.L. 117-103, Division P, Title III, Subtitle A Telehealth Flexibility Extension; H.R. 1677/S. 620, the KEEP Telehealth Options Act, and Discussion Draft of bipartisan Senate Finance Committee legislation, the Telemental Health Access to Care Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act, and H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements; use of step therapy in Medicare and health insurance coverage; including related provisions in H.R. 5376 the Build Back Better Act, including provisions regarding Lowering Prices Through Drug Price Negotiation, establishment of a Drug Price Negotiation Program, and Medicare Inflation Rebates, including related provisions in Sections 139001, 139002, 139101, and 139102, and related provisions in the Senate Finance Committee posted amendment to H.R. 5376; and S. 464/H.R. 2163, the Safe Step Act; and antibiotic development incentives, including related provisions in H.R. 4172, to encourage the development and use of certain antimicrobial drugs and H.R. 3932, to establish a program to develop antimicrobial innovations. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including the Most Favored Nation demonstration.

Medicare quality standards for hospitals and transplant programs. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives.

Legislative and regulatory matters related to reimbursement for radiation oncology treatment; including implementation of related provisions in H.R. 2029, Consolidated Appropriations Act, regarding incentives for digital radiography. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Health care reform including implementation of the Affordable Care Act. Monitor implementation of the No Surprises Act. Coronavirus response efforts, including support for health care providers, patients and small business, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Recovery audit contractor reform. Medicare regulatory reform, including physician payment reforms. Network adequacy oversight. Prior authorization reform. Medicare accountable care organizations. Electronic health record interoperability and vendor accountability. Physician-owned-hospital barriers, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act. Coronavirus response efforts, including support for health care providers, patients and small business, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Medicare physician fee schedule and sequestration relief. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including: (1) provisions in H.R. 5376, the Build Back Better Act, Section 139001, to establish a Drug Price Negotiation Program, and modify Medicare Part B reimbursement by application of Maximum Fair Prices and Conforming Amendments, to selected Medicare Part B covered drugs; and (2) monitor the CMMI Most Favored Nation demonstration.

340B Program issues and patient access to pharmaceuticals, including related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2) and including related provisions in H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Center for Medicare & Medicaid Innovation demonstration for periodontal services for targeted, low-income Medicare beneficiaries and monitor Medicare dental benefit issues, including medically necessary dental coverage in Medicare, and related provisions in S. 97/H.R. 502, the Medicare Dental Benefit Act, and monitor H.R. 5376 the Build Back Better Act, and related amendments to H.R. 5376 posted by the Senate Finance Committee. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and support for health care providers and patients, implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Ophthalmologists' services in Department of Veterans Affairs programs. Coronavirus response and support for health care providers and patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor implementation of Surprise Medical Billing law. Advocacy on Risk Evaluation and Mitigation Strategy (REMS) issues.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2021, Division P, Title III, Subtitle A Telehealth Flexibility Extension; and H.R. 1677/S. 620, the KEEP Telehealth Options Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Monitor implementation of healthcare quality, cost, and access and related health care reform efforts. Coronavirus response efforts, including support for health care providers and patients, and related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Medicare quality standards for hospitals and transplant programs. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2. Enhance Center for Medicare & Medicaid Innovation quality initiatives.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-owned hospitals, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-owned hospitals. Coronavirus response efforts, including support for health care providers, patients and small business, and enable physician-owned hospitals to respond to COVID-19, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Ophthalmologists' services in Department of Veterans Affairs programs. Coronavirus response and support for health care providers and patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor implementation of Surprise Medical Billing law.

Legislative and regulatory matters related to reimbursement for radiation oncology treatment; including implementation of related provisions in H.R. 2029, Consolidated Appropriations Act, regarding incentives for digital radiography. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Recovery audit contractor reform. Medicare regulatory reform, including physician payment reforms. Network adequacy oversight. Prior authorization reform, including related provisions in H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans, and H.R. 3173/S. 3018, the Ensuring Seniors Timely Access to Care Act. Medicare accountable care organizations. Electronic health record interoperability and vendor accountability. Physician-owned-hospital barriers, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act, and S. 4130, the Patient Access to Higher Quality Care Act of 2022. Coronavirus response efforts, including support for health care providers, patients and small business, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Medicare physician fee schedule and sequestration relief. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including: (1) provisions in H.R. 5376, the Build Back Better Act, Section 139001, to establish a Drug Price Negotiation Program, and modify Medicare Part B reimbursement by application of Maximum Fair Prices and Conforming Amendments, to selected Medicare Part B covered drugs; and (2) monitor the CMMI Most Favored Nation demonstration.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-owned hospitals, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act of 2021, and S. 4130, the Patient Access to Higher Quality Care Act of 2022; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-owned hospitals. Coronavirus response efforts, including support for health care providers, patients and small business, and enable physician-owned hospitals to respond to COVID-19, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-owned hospitals, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-owned hospitals. Coronavirus response efforts, including support for health care providers, patients and small business, and enable physician-owned hospitals to respond to COVID-19, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Recovery audit contractor reform. Medicare regulatory reform, including physician payment reforms. Network adequacy oversight. Prior authorization reform. Medicare accountable care organizations. Electronic health record interoperability and vendor accountability. Physician-owned-hospital barriers, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act. Coronavirus response efforts, including support for health care providers, patients and small business, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Medicare physician fee schedule and sequestration relief. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including: (1) provisions in H.R. 5376, the Build Back Better Act, Section 139001, to establish a Drug Price Negotiation Program, and modify Medicare Part B reimbursement by application of Maximum Fair Prices and Conforming Amendments, to selected Medicare Part B covered drugs; and (2) monitor the CMMI Most Favored Nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Monitor healthcare reform and quality initiatives, including implementation of related provisions in the Affordable Care Act. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act and H.R.1667, Dr. Lorna Breen Health Care Provider Protection Act (Public Law No: 117-105), and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Monitor healthcare reform and quality initiatives, including implementation of related provisions in the Affordable Care Act. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act and H.R.1667, Dr. Lorna Breen Health Care Provider Protection Act (Public Law No: 117-105), and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2022, P.L. 117-103, Division P, Title III, Subtitle A Telehealth Flexibility Extension; H.R. 1677/S. 620, the KEEP Telehealth Options Act, and Discussion Draft of bipartisan Senate Finance Committee legislation, the Telemental Health Access to Care Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act, and H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2021, Division P, Title III, Subtitle A Telehealth Flexibility Extension; and H.R. 1677/S. 620, the KEEP Telehealth Options Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Legislative and regulatory matters related to reimbursement for radiation oncology treatment; including implementation of related provisions in H.R. 2029, Consolidated Appropriations Act, regarding incentives for digital radiography. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Legislative and regulatory matters related to reimbursement for radiation oncology treatment; including implementation of related provisions in H.R. 2029, Consolidated Appropriations Act, regarding incentives for digital radiography. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

340B Program issues and patient access to pharmaceuticals, including related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022, P.L. 117-103. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines, including related provisions in H.R. 7667, Food and Drug Amendments Act and S. 4348, Food and Drug Administration Safety and Landmark Advancements Act; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2) and H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2022, P.L. 117-103, Division P, Title III, Subtitle A Telehealth Flexibility Extension; H.R. 1677/S. 620, the KEEP Telehealth Options Act, and Discussion Draft of bipartisan Senate Finance Committee legislation, the Telemental Health Access to Care Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act, and H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

340B Program issues and patient access to pharmaceuticals, including related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2) and including related provisions in H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements; use of step therapy in Medicare and health insurance coverage; including related provisions in H.R. 5376 the Build Back Better Act, including provisions regarding Lowering Prices Through Drug Price Negotiation, establishment of a Drug Price Negotiation Program, and Medicare Inflation Rebates, including related provisions in Sections 139001, 139002, 139101, and 139102, and related provisions in the Senate Finance Committee posted amendment to H.R. 5376; and S. 464/H.R. 2163, the Safe Step Act; and antibiotic development incentives, including related provisions in H.R. 4172, P.L. 117-57, to encourage the development and use of certain antimicrobial drugs and H.R. 3932, to establish a program to develop antimicrobial innovations. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including the Most Favored Nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2021, Division P, Title III, Subtitle A Telehealth Flexibility Extension; and H.R. 1677/S. 620, the KEEP Telehealth Options Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements; use of step therapy in Medicare and health insurance coverage; including related provisions in H.R. 5376 the Build Back Better Act, including provisions regarding Lowering Prices Through Drug Price Negotiation, establishment of a Drug Price Negotiation Program, and Medicare Inflation Rebates, including related provisions in Sections 139001, 139002, 139101, and 139102, and related provisions in the Senate Finance Committee posted amendment to H.R. 5376; and S. 464/H.R. 2163, the Safe Step Act; and antibiotic development incentives, including related provisions in H.R. 4172, to encourage the development and use of certain antimicrobial drugs and H.R. 3932, to establish a program to develop antimicrobial innovations. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including the Most Favored Nation demonstration.

340B Program issues and patient access to pharmaceuticals, including related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2) and including related provisions in H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

340B Program issues and patient access to pharmaceuticals, including related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022, P.L. 117-103. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines, including related provisions in H.R. 7667, Food and Drug Amendments Act and S. 4348, Food and Drug Administration Safety and Landmark Advancements Act; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2) and H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2021, Division P, Title III, Subtitle A Telehealth Flexibility Extension; and H.R. 1677/S. 620, the KEEP Telehealth Options Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2022, P.L. 117-103, Division P, Title III, Subtitle A Telehealth Flexibility Extension; H.R. 1677/S. 620, the KEEP Telehealth Options Act, and Discussion Draft of bipartisan Senate Finance Committee legislation, the Telemental Health Access to Care Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act, and H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Recovery audit contractor reform. Medicare regulatory reform, including physician payment reforms. Network adequacy oversight. Prior authorization reform, including related provisions in H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans, and H.R. 3173/S. 3018, the Ensuring Seniors Timely Access to Care Act. Medicare accountable care organizations. Electronic health record interoperability and vendor accountability. Physician-owned-hospital barriers, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act, and S. 4130, the Patient Access to Higher Quality Care Act of 2022. Coronavirus response efforts, including support for health care providers, patients and small business, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Medicare physician fee schedule and sequestration relief. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including: (1) provisions in H.R. 5376, the Build Back Better Act, Section 139001, to establish a Drug Price Negotiation Program, and modify Medicare Part B reimbursement by application of Maximum Fair Prices and Conforming Amendments, to selected Medicare Part B covered drugs; and (2) monitor the CMMI Most Favored Nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2022, P.L. 117-103, Division P, Title III, Subtitle A Telehealth Flexibility Extension; H.R. 1677/S. 620, the KEEP Telehealth Options Act, and Discussion Draft of bipartisan Senate Finance Committee legislation, the Telemental Health Access to Care Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act, and H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2021, Division P, Title III, Subtitle A Telehealth Flexibility Extension; and H.R. 1677/S. 620, the KEEP Telehealth Options Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements; use of step therapy in Medicare and health insurance coverage; including related provisions in H.R. 5376 the Build Back Better Act, including provisions regarding Lowering Prices Through Drug Price Negotiation, establishment of a Drug Price Negotiation Program, and Medicare Inflation Rebates, including related provisions in Sections 139001, 139002, 139101, and 139102, and related provisions in the Senate Finance Committee posted amendment to H.R. 5376; and S. 464/H.R. 2163, the Safe Step Act; and antibiotic development incentives, including related provisions in H.R. 4172, P.L. 117-57, to encourage the development and use of certain antimicrobial drugs and H.R. 3932, to establish a program to develop antimicrobial innovations. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including the Most Favored Nation demonstration.

Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements; use of step therapy in Medicare and health insurance coverage; including related provisions in H.R. 5376 the Build Back Better Act, including provisions regarding Lowering Prices Through Drug Price Negotiation, establishment of a Drug Price Negotiation Program, and Medicare Inflation Rebates, including related provisions in Sections 139001, 139002, 139101, and 139102, and related provisions in the Senate Finance Committee posted amendment to H.R. 5376; and S. 464/H.R. 2163, the Safe Step Act; and antibiotic development incentives, including related provisions in H.R. 4172, to encourage the development and use of certain antimicrobial drugs and H.R. 3932, to establish a program to develop antimicrobial innovations. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including the Most Favored Nation demonstration.

Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements; use of step therapy in Medicare and health insurance coverage; including related provisions in H.R. 5376 the Build Back Better Act, including provisions regarding Lowering Prices Through Drug Price Negotiation, establishment of a Drug Price Negotiation Program, and Medicare Inflation Rebates, including related provisions in Sections 139001, 139002, 139101, and 139102, and related provisions in the Senate Finance Committee posted amendment to H.R. 5376; and S. 464/H.R. 2163, the Safe Step Act; and antibiotic development incentives, including related provisions in H.R. 4172, P.L. 117-57, to encourage the development and use of certain antimicrobial drugs and H.R. 3932, to establish a program to develop antimicrobial innovations. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including the Most Favored Nation demonstration.

Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements; use of step therapy in Medicare and health insurance coverage; including related provisions in H.R. 5376 the Build Back Better Act, including provisions regarding Lowering Prices Through Drug Price Negotiation, establishment of a Drug Price Negotiation Program, and Medicare Inflation Rebates, including related provisions in Sections 139001, 139002, 139101, and 139102, and related provisions in the Senate Finance Committee posted amendment to H.R. 5376; and S. 464/H.R. 2163, the Safe Step Act; and antibiotic development incentives, including related provisions in H.R. 4172, to encourage the development and use of certain antimicrobial drugs and H.R. 3932, to establish a program to develop antimicrobial innovations. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including the Most Favored Nation demonstration.

Center for Medicare & Medicaid Innovation demonstration for periodontal services for targeted, low-income Medicare beneficiaries and monitor Medicare dental benefit issues, including medically necessary dental coverage in Medicare, and related provisions in S. 97/H.R. 502, the Medicare Dental Benefit Act, and monitor H.R. 5376 the Build Back Better Act, and related amendments to H.R. 5376 posted by the Senate Finance Committee. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and support for health care providers and patients, implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Center for Medicare & Medicaid Innovation demonstration for periodontal services for targeted, low-income Medicare beneficiaries and monitor Medicare dental benefit issues, including related provisions in S. 97/H.R. 502, the Medicare Dental Benefit Act, and monitor H.R. 5376 the Build Back Better Act, and related amendments to H.R. 5376 posted by the Senate Finance Committee. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and support for health care providers and patients, implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Issues pertaining to public mental health programs, Medicare, Medicaid, substance-use disorder care, healthcare workforce and integrated care models. Issues regarding telehealth and legislation pertaining to collaborative care and mental health parity. Working for passage of the Collaborate in an Orderly and Cohesive Manner Act (H.R. 5218).

Issues pertaining to public mental health programs, Medicare, Medicaid, substance-use disorder care, healthcare workforce and integrated care models. Issues regarding telehealth and legislation pertaining to collaborative care and mental health parity. Working for passage of the Collaborate in an Orderly and Cohesive Manner Act (H.R. 5218).

Medical Supply Chain, including issues related to strengthening trade relationships through negotiations with the United States Trade Representative (USTR) and US partners to develop appropriate sources to help secure the US supply chain, along with coordination with trade partners to maintain free movement of goods, including related provisions in H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

Medical Supply Chain, including issues related to strengthening trade relationships through negotiations with the United States Trade Representative (USTR) and US partners to develop appropriate sources to help secure the US supply chain, along with coordination with trade partners to maintain free movement of goods, including related provisions in H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

Recovery audit contractor reform. Medicare regulatory reform, including physician payment reforms. Network adequacy oversight. Prior authorization reform, including related provisions in H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans, and H.R. 3173/S. 3018, the Ensuring Seniors Timely Access to Care Act. Medicare accountable care organizations. Electronic health record interoperability and vendor accountability. Physician-owned-hospital barriers, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act, and S. 4130, the Patient Access to Higher Quality Care Act of 2022. Coronavirus response efforts, including support for health care providers, patients and small business, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Medicare physician fee schedule and sequestration relief. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including: (1) provisions in H.R. 5376, the Build Back Better Act, Section 139001, to establish a Drug Price Negotiation Program, and modify Medicare Part B reimbursement by application of Maximum Fair Prices and Conforming Amendments, to selected Medicare Part B covered drugs; and (2) monitor the CMMI Most Favored Nation demonstration.

Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements; use of step therapy in Medicare and health insurance coverage; including related provisions in H.R. 5376 the Build Back Better Act, including provisions regarding Lowering Prices Through Drug Price Negotiation, establishment of a Drug Price Negotiation Program, and Medicare Inflation Rebates, including related provisions in Sections 139001, 139002, 139101, and 139102, and related provisions in the Senate Finance Committee posted amendment to H.R. 5376; and S. 464/H.R. 2163, the Safe Step Act; and antibiotic development incentives, including related provisions in H.R. 4172, to encourage the development and use of certain antimicrobial drugs and H.R. 3932, to establish a program to develop antimicrobial innovations. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including the Most Favored Nation demonstration.

Center for Medicare & Medicaid Innovation demonstration for periodontal services for targeted, low-income Medicare beneficiaries and monitor Medicare dental benefit issues, including related provisions in S. 97/H.R. 502, the Medicare Dental Benefit Act, and monitor H.R. 5376 the Build Back Better Act, and related amendments to H.R. 5376 posted by the Senate Finance Committee. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and support for health care providers and patients, implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

340B Program issues and patient access to pharmaceuticals, including related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022, P.L. 117-103. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines, including related provisions in H.R. 7667, Food and Drug Amendments Act and S. 4348, Food and Drug Administration Safety and Landmark Advancements Act; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2) and H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

Recovery audit contractor reform. Medicare regulatory reform, including physician payment reforms. Network adequacy oversight. Prior authorization reform. Medicare accountable care organizations. Electronic health record interoperability and vendor accountability. Physician-owned-hospital barriers, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act. Coronavirus response efforts, including support for health care providers, patients and small business, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Medicare physician fee schedule and sequestration relief. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including: (1) provisions in H.R. 5376, the Build Back Better Act, Section 139001, to establish a Drug Price Negotiation Program, and modify Medicare Part B reimbursement by application of Maximum Fair Prices and Conforming Amendments, to selected Medicare Part B covered drugs; and (2) monitor the CMMI Most Favored Nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2022, P.L. 117-103, Division P, Title III, Subtitle A Telehealth Flexibility Extension; H.R. 1677/S. 620, the KEEP Telehealth Options Act, and Discussion Draft of bipartisan Senate Finance Committee legislation, the Telemental Health Access to Care Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act, and H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2021, Division P, Title III, Subtitle A Telehealth Flexibility Extension; and H.R. 1677/S. 620, the KEEP Telehealth Options Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Medicare beneficiary access to treatments for Alzheimers disease, including Medicare Part B access issues, including related provisions in H.R. 5376, the Build Back Better Act, including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Conforming Amendments to modify Medicare Part B reimbursement for selected drugs.

Medicare beneficiary access to treatments for Alzheimers disease, including Medicare Part B access issues, including related provisions in H.R. 5376, the Build Back Better Act, including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Conforming Amendments to modify Medicare Part B reimbursement for selected drugs.

340B Program issues and patient access to pharmaceuticals, including related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2) and including related provisions in H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

Center for Medicare & Medicaid Innovation demonstration for periodontal services for targeted, low-income Medicare beneficiaries and monitor Medicare dental benefit issues, including medically necessary dental coverage in Medicare, and related provisions in S. 97/H.R. 502, the Medicare Dental Benefit Act, and monitor H.R. 5376 the Build Back Better Act, and related amendments to H.R. 5376 posted by the Senate Finance Committee. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and support for health care providers and patients, implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements; use of step therapy in Medicare and health insurance coverage; including related provisions in H.R. 5376 the Build Back Better Act, including provisions regarding Lowering Prices Through Drug Price Negotiation, establishment of a Drug Price Negotiation Program, and Medicare Inflation Rebates, including related provisions in Sections 139001, 139002, 139101, and 139102, and related provisions in the Senate Finance Committee posted amendment to H.R. 5376; and S. 464/H.R. 2163, the Safe Step Act; and antibiotic development incentives, including related provisions in H.R. 4172, P.L. 117-57, to encourage the development and use of certain antimicrobial drugs and H.R. 3932, to establish a program to develop antimicrobial innovations. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including the Most Favored Nation demonstration.

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

340B Program issues and patient access to pharmaceuticals, including related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022, P.L. 117-103. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines, including related provisions in H.R. 7667, Food and Drug Amendments Act and S. 4348, Food and Drug Administration Safety and Landmark Advancements Act; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2) and H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

Recovery audit contractor reform. Medicare regulatory reform, including physician payment reforms. Network adequacy oversight. Prior authorization reform, including related provisions in H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans, and H.R. 3173/S. 3018, the Ensuring Seniors Timely Access to Care Act. Medicare accountable care organizations. Electronic health record interoperability and vendor accountability. Physician-owned-hospital barriers, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act, and S. 4130, the Patient Access to Higher Quality Care Act of 2022. Coronavirus response efforts, including support for health care providers, patients and small business, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Medicare physician fee schedule and sequestration relief. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including: (1) provisions in H.R. 5376, the Build Back Better Act, Section 139001, to establish a Drug Price Negotiation Program, and modify Medicare Part B reimbursement by application of Maximum Fair Prices and Conforming Amendments, to selected Medicare Part B covered drugs; and (2) monitor the CMMI Most Favored Nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2022, P.L. 117-103, Division P, Title III, Subtitle A Telehealth Flexibility Extension; H.R. 1677/S. 620, the KEEP Telehealth Options Act, and Discussion Draft of bipartisan Senate Finance Committee legislation, the Telemental Health Access to Care Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act, and H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2022, P.L. 117-103, Division P, Title III, Subtitle A Telehealth Flexibility Extension; H.R. 1677/S. 620, the KEEP Telehealth Options Act, and Discussion Draft of bipartisan Senate Finance Committee legislation, the Telemental Health Access to Care Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act, and H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Recovery audit contractor reform. Medicare regulatory reform, including physician payment reforms. Network adequacy oversight. Prior authorization reform, including related provisions in H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans, and H.R. 3173/S. 3018, the Ensuring Seniors Timely Access to Care Act. Medicare accountable care organizations. Electronic health record interoperability and vendor accountability. Physician-owned-hospital barriers, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act, and S. 4130, the Patient Access to Higher Quality Care Act of 2022. Coronavirus response efforts, including support for health care providers, patients and small business, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Medicare physician fee schedule and sequestration relief. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including: (1) provisions in H.R. 5376, the Build Back Better Act, Section 139001, to establish a Drug Price Negotiation Program, and modify Medicare Part B reimbursement by application of Maximum Fair Prices and Conforming Amendments, to selected Medicare Part B covered drugs; and (2) monitor the CMMI Most Favored Nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2021, Division P, Title III, Subtitle A Telehealth Flexibility Extension; and H.R. 1677/S. 620, the KEEP Telehealth Options Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Health care reform including implementation of the Affordable Care Act. Monitor implementation of the No Surprises Act. Coronavirus response efforts, including support for health care providers, patients and small business, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Monitor implementation of healthcare quality, cost, and access and related health care reform efforts. Coronavirus response efforts, including support for health care providers and patients, and related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Medicare quality standards for hospitals and transplant programs. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2. Enhance Center for Medicare & Medicaid Innovation quality initiatives.

Monitor implementation of healthcare quality, cost, and access and related health care reform efforts. Coronavirus response efforts, including support for health care providers and patients, and related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2021, Division P, Title III, Subtitle A Telehealth Flexibility Extension; and H.R. 1677/S. 620, the KEEP Telehealth Options Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Health care reform including implementation of the Affordable Care Act. Monitor implementation of the No Surprises Act. Coronavirus response efforts, including support for health care providers, patients and small business, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).